Komori
Toli (7971) · RiskRestated

Risk of failing to develop competitive new products

First written in FY2016. 21 of 22 entries say "Restated". Latest entry: FY2025-H1.

22entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2025-H12016: 320162017: 420172018: 320182019: 220192020: 320202021: 320212022: 120222023: 220232024: 12024
Same theme, other companies
Risk of Failure to Achieve Results from R&D InvestmentA theme 115 companies write about · 115 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2026: 14 of 29 companies on the "Worse" side.

74 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 115 companies compared. The sentences above are computed from all 115.
Full recordFilings, disclosures and news, newest first
  1. FY2025-H1RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no additional occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  2. FY2024-Q2RestatedAnnual report

    「No new business or other risks arose during the cumulative second quarter of the current consolidated fiscal year. There have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The disclosure states that there have been no additional occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  3. FY2023-Q3RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the third quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  4. FY2022-Q3RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the third quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  5. FY2022-Q1RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the first quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no additional occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  6. FY2021RestatedAnnual report

    「However, because research and development activities are inherently uncertain in their outcomes, the Group may be unable to develop sufficiently competitive new products. In such cases, the Group's operating results and financial position may be affected.」

    While continuing research and development, the Group has reconfirmed the risks of uncertain outcomes and failure to develop new products, as well as the responses of reviewing investments in important projects and reporting on their progress.
  7. FY2021-Q3RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the third quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no additional occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  8. FY2021-Q2RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the second quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no additional occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  9. FY2020RestatedAnnual report

    「However, because research and development activities are inherently uncertain in their outcomes, the Group may be unable to develop sufficiently competitive new products.」

    The uncertainty of research and development outcomes is described as an ongoing risk, with investment reviews and progress reports conducted for important projects.
  10. FY2020-Q3RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the third quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no additional occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  11. FY2020-Q2RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the second quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no additional occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  12. FY2019-Q3RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the third quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  13. FY2019-Q2RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the second quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  14. FY2019-Q1RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the first quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  15. FY2018-Q3RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the third quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  16. FY2018-Q2RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the second quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no additional occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  17. FY2018-Q1RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the first quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  18. FY2017RestatedAnnual report

    「To strengthen its competitiveness over the long term, the Group conducts basic research into new materials and processing technologies. However, because research and development activities are inherently uncertain in their outcomes, the Group may be unable to develop sufficiently competitive new products.」

    While research and development is used to strengthen competitiveness, the uncertainty of its outcomes has been reconfirmed as a risk.
  19. FY2017-Q3RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the third quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no additional occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  20. FY2017-Q2RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the second quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no additional occurrences or material changes in the risk of being unable to develop sufficiently competitive new products.
  21. FY2017-Q1RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the first quarter. Nor were there any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no material changes in the risk of being unable to develop sufficiently competitive new products.
  22. FY2016First statedAnnual report

    「Because research and development activities are inherently uncertain in their outcomes, the Group may be unable to develop sufficiently competitive new products.」

    While research and development is positioned as a growth initiative, the uncertainty of its outcomes is explicitly identified as a risk.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Toli's next results are scheduled for 2026-11-02. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of failing to develop competitive new products | TOLI Corporation (7971) | Komori